MBD2
Basic information
Region (hg38): 18:54151606-54224669
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MBD2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 24 | 24 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 24 | 0 | 1 |
Variants in MBD2
This is a list of pathogenic ClinVar variants found in the MBD2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
18-54159821-T-C | not specified | Uncertain significance (Aug 05, 2023) | ||
18-54159832-C-T | not specified | Uncertain significance (Mar 24, 2023) | ||
18-54164588-A-G | Benign (Dec 31, 2019) | |||
18-54188997-C-G | not specified | Uncertain significance (Dec 06, 2021) | ||
18-54224091-G-C | not specified | Uncertain significance (Oct 26, 2021) | ||
18-54224122-G-C | not specified | Uncertain significance (Nov 29, 2023) | ||
18-54224150-C-A | not specified | Uncertain significance (Sep 22, 2022) | ||
18-54224151-C-G | not specified | Uncertain significance (Sep 22, 2022) | ||
18-54224185-C-A | not specified | Uncertain significance (Apr 19, 2023) | ||
18-54224214-T-C | not specified | Uncertain significance (May 30, 2024) | ||
18-54224223-C-A | not specified | Uncertain significance (Apr 07, 2023) | ||
18-54224235-C-A | not specified | Uncertain significance (May 24, 2023) | ||
18-54224237-C-T | not specified | Uncertain significance (May 15, 2024) | ||
18-54224255-C-G | not specified | Uncertain significance (Feb 16, 2023) | ||
18-54224271-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
18-54224280-G-A | not specified | Uncertain significance (Dec 11, 2023) | ||
18-54224352-C-T | not specified | Uncertain significance (Jun 05, 2023) | ||
18-54224358-C-G | not specified | Uncertain significance (Apr 05, 2023) | ||
18-54224367-T-C | not specified | Uncertain significance (Jun 06, 2023) | ||
18-54224397-G-A | not specified | Uncertain significance (Oct 05, 2021) | ||
18-54224400-C-G | not specified | Uncertain significance (Jul 11, 2022) | ||
18-54224415-C-A | not specified | Uncertain significance (Dec 15, 2021) | ||
18-54224429-G-A | not specified | Uncertain significance (Mar 28, 2023) | ||
18-54224432-G-A | not specified | Uncertain significance (Dec 09, 2023) | ||
18-54224432-G-T | not specified | Uncertain significance (May 27, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MBD2 | protein_coding | protein_coding | ENST00000256429 | 6 | 72080 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.350 | 0.650 | 125733 | 0 | 7 | 125740 | 0.0000278 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.11 | 85 | 160 | 0.531 | 0.00000775 | 2624 |
Missense in Polyphen | 12 | 56.472 | 0.21249 | 751 | ||
Synonymous | 1.06 | 48 | 58.2 | 0.824 | 0.00000303 | 850 |
Loss of Function | 2.99 | 4 | 17.5 | 0.228 | 0.00000110 | 189 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.0000494 | 0.0000462 |
European (Non-Finnish) | 0.0000352 | 0.0000352 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides. Binds hemimethylated DNA as well. Recruits histone deacetylases and DNA methyltransferases. Acts as transcriptional repressor and plays a role in gene silencing. Functions as a scaffold protein, targeting GATAD2A and GATAD2B to chromatin to promote repression. May enhance the activation of some unmethylated cAMP-responsive promoters. {ECO:0000269|PubMed:10471499, ECO:0000269|PubMed:10947852, ECO:0000269|PubMed:12665568, ECO:0000269|PubMed:16415179, ECO:0000269|PubMed:24307175, ECO:0000269|PubMed:9774669}.;
- Pathway
- NoRC negatively regulates rRNA expression;Negative epigenetic regulation of rRNA expression;Epigenetic regulation of gene expression;Gene expression (Transcription);RNA Polymerase I Promoter Clearance;RNA Polymerase I Promoter Opening;RNA Polymerase I Transcription;Signaling events mediated by HDAC Class I
(Consensus)
Recessive Scores
- pRec
- 0.328
Intolerance Scores
- loftool
- 0.326
- rvis_EVS
- -0.1
- rvis_percentile_EVS
- 46.2
Haploinsufficiency Scores
- pHI
- 0.564
- hipred
- Y
- hipred_score
- 0.794
- ghis
- 0.613
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- K
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.747
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Mbd2
- Phenotype
- mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; neoplasm; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan);
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;chromatin silencing at rDNA;methylation-dependent chromatin silencing;heart development;aging;response to mechanical stimulus;positive regulation of Wnt signaling pathway;response to nutrient levels;response to estradiol;cellular protein-containing complex assembly;positive regulation of chromatin binding;regulation of cell population proliferation;maternal behavior;ATP-dependent chromatin remodeling;regulation of DNA methylation;negative regulation of transcription, DNA-templated;embryonic organ development;cellular response to organic cyclic compound
- Cellular component
- histone deacetylase complex;nuclear chromatin;heterochromatin;nucleus;nucleoplasm;cytosol;protein-containing complex
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;satellite DNA binding;mRNA binding;protein binding;methyl-CpG binding;protein domain specific binding;nucleosomal DNA binding;siRNA binding;C2H2 zinc finger domain binding